Organic germanium, most commonly found as bis-carboxyethyl germanium sesquioxide (Ge-132), is a trace mineral compound that has attracted scientific interest since the 1970s for its potential role in supporting immune function and antioxidant activity. Research suggests that Ge-132 may help stimulate certain immune responses, including natural killer cell activity and interferon production, though much of this evidence comes from preclinical and early-stage studies. Some investigations have also explored its potential benefits for urinary tract health and its ability to support oxygen utilization at the cellular level. It is important to distinguish organic germanium (Ge-132) from inorganic germanium compounds, which have been associated with toxicity. While preliminary findings are promising, more robust human clinical trials are needed to fully understand its benefits and long-term safety profile.
Compare this supplementResearch suggests that organic germanium compounds, particularly Ge-132 and related synthetic derivatives, may modula...
View studies →Research suggests that the available study linked to organic germanium and antioxidant support does not directly inve...
View studies →Research suggests that organic germanium supplements pose significant risks to urinary tract and kidney health, with ...
View studies →These are commonly referenced dosage ranges for this supplement. They are not medical recommendations. Always consult a healthcare provider before supplementing.
| Form | Dose range | Frequency | Studied for | Source |
|---|---|---|---|---|
| Capsule | 25–100 mg | Daily | immune function support | Doses referenced in immune modulation research with organic germanium (Ge-132) |
| Powder | 100–200 mg | Daily | urinary tract health and antioxidant support | Referenced in traditional and supplemental use literature for Ge-132 oral administration |
| Tablet | 100–300 mg | Daily | general health and antioxidant support | Common in early clinical and observational studies using Ge-132 (bis-carboxyethyl germanium sesquioxide) |
| Tablet | 500–1,000 mg | Daily | investigational use in cancer and chronic illness studies | Higher doses studied in Japanese clinical settings; safety concerns noted at prolonged high doses |